drug · antibody
petosemtamab
Phase 3updated 3mo agoby Merus NV🔗 ChEMBL
Phase 3community read0 votes
Antibody drug with a maximum clinical stage of Phase 1, with 1 investigational indication.
all catalysts(0)
nothing on the calendar yet
Trials studying petosemtamab
- phase3Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer
- phase3A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)
- phase2Study to Investigate Petosemtamab in Adults With Metastatic Non-Small Cell Lung Cancer
- phase3A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 50m ago
Found something off?
comments(0)
5-min edit window · permanent after that